论文部分内容阅读
盆腔脏器脱垂(pelvic organ prolapse,POP)与尿失禁共同称作女性盆底功能障碍性疾病(pelvic floor dysfunction,PFD)[1]。流行病学调查显示,其人群发病率50~59岁约占12.5%[2],60岁以上者占76.7%[3],随着人口老龄化,POP患者会逐渐增多。TeLinde’s Operative Gynecology[4]中指出,POP是一种影响患者生活质量的疾病,所以任何关于治疗的选择都应该由患者做出。因为POP是一种不危及生命的疾病,只有当患者自觉脱垂症状影响生活质量要求治疗时,才需要临床处理。治疗方式主要包
Pelvic organ prolapse (POP) and urinary incontinence are collectively referred to as pelvic floor dysfunction (PFD) [1]. Epidemiological survey showed that the incidence of the population of 50 to 59 years old accounted for about 12.5% [2], over the age of 76 accounted for 76.7% [3], with the population aging, POP patients will gradually increase. TeLinde’s Operative Gynecology [4] pointed out that POP is a disease affecting the quality of life of patients, so any choice of treatment should be made by the patient. Because POP is a non-life-threatening disease, clinical treatment is only needed if the patient is conscious of prolapse symptoms that affect quality of life. The main treatment package